Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYCLIC FLOW VARIATIONS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 74 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Maayani, S; Schwarz, T; Craddock-Royal, B; Tagliente, TM
      Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro

      PLATELETS
    2. Maayani, S; Tagliente, TM; Schwarz, T; Craddock-Royal, B; Alcala, C; Marrero, G; Martinez, R
      Deaggregation is an integral component of the response of platelets to ADPin vitro: kinetic studies of literature and original data

      PLATELETS
    3. Maayani, S; Tagliente, TM; Schwarz, T; Martinelli, G; Martinez, R; Shore-Lesserson, L
      The balance of concurrent aggregation and deaggregation processes in platelets is linked to differential occupancy of ADP receptor subtypes

      PLATELETS
    4. Przyklenk, K; Kloner, RA
      Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    5. Kageyama, S; Yamamoto, H; Nakazawa, H; Yoshimoto, R
      Anti-human vWF monoclonal antibody, AJvW-2 fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs

      THROMBOSIS RESEARCH
    6. Kanaya, S; Ikeda, H; Haramaki, N; Murohara, T; Imaizumi, T
      Intraplatelet tetrahydrobiopterin plays an important role in regulating canine coronary arterial thrombosis by modulating intraplatelet nitric oxide and superoxide generation

      CIRCULATION
    7. Kushwaha, SS; Ambrose, JA
      Does ischemic preconditioning limit infarct size in non-Q-wave myocardial infarction?

      CORONARY ARTERY DISEASE
    8. Zoldhelyi, P; Beck, PJ; Bjercke, RJ; Ober, JC; Hu, X; McNatt, JM; Akhtar, S; Ahmed, M; Clubb, FJ; Chen, ZQ; Dixon, RAF; Yeh, ETH; Willerson, JT
      Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    9. Przyklenk, K; Hata, K; Whittaker, P; Elliott, GT
      Monophosphoryl lipid A: A novel nitric oxide-mediated therapy to attenuateplatelet thrombosis?

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    10. Zoldhelyi, P; McNatt, J; Shelat, HS; Yamamoto, Y; Chen, ZQ; Willerson, JT
      Thromboresistance of balloon-injured porcine carotid arteries after local gene transfer of human tissue factor pathway inhibitor

      CIRCULATION
    11. Mruk, JS; Webster, MWI; Heras, M; Reid, JM; Grill, DE; Chesebro, JH
      Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo

      CIRCULATION
    12. Herbert, JM; Savi, P; Maffrand, JP
      Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    13. Ikeda, H; Ueyama, T; Murahara, T; Yasukawa, H; Haramaki, N; Eguchi, H; Katoh, A; Takajo, Y; Onitsuka, I; Ueno, T; Tojo, SJ; Imaizumi, T
      Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    14. Folts, JD; Schafer, AI; Loscalzo, J; Willerson, JT; Muller, JE
      A perspective on the potential problems with aspirin as an antithrombotic agent: A comparison of studies in an animal model with clinical trials

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    15. Herbert, JM; Savi, P; Maffrand, JP
      Biochemical and pharmacological properties of clopidogrel: a new ADP receptor antagonist

      EUROPEAN HEART JOURNAL
    16. Soyka, R; Guth, BD; Weisenberger, HM; Luger, P; Muller, T
      Guanidine derivatives as combined thromboxane A(2) receptor antagonists and synthase inhibitors

      JOURNAL OF MEDICINAL CHEMISTRY
    17. Eguchi, H; Ikeda, H; Murohara, T; Yasukawa, H; Haramaki, N; Sakisaka, S; Imaizumi, T
      Endothelial injuries of coronary arteries distal to thrombotic sites - Role of adhesive interaction between endothelial P-selectin and leukocyte sialyl Lewis(X)

      CIRCULATION RESEARCH
    18. Vikenes, K; Farstad, M; Nordrehaug, JE
      Serotonin is associated with coronary artery disease and cardiac events

      CIRCULATION
    19. Leosco, D; Fineschi, M; Pierli, C; Fiaschi, A; Ferrara, N; Bianco, S; Longobardi, G; Pisani, E; Bravi, A; Rengo, F
      Intracoronary serotonin release after high-pressure coronary stenting

      AMERICAN JOURNAL OF CARDIOLOGY
    20. IRANI K; PHAM Y; COLEMAN LD; ROOS C; COOKE GE; MIODOVNIK A; KARIM N; WILHIDE CC; BRAY PF; GOLDSCHMIDTCLERMONT PJ
      PRIMING OF PLATELET ALPHA(IIB)BETA(3) BY OXIDANTS IS ASSOCIATED WITH TYROSINE PHOSPHORYLATION OF BETA(3)

      Arteriosclerosis, thrombosis, and vascular biology
    21. BROEDERS MAW; TANGELDER GJ; SLAAF DW; RENEMAN RS; EGBRINK MGAO
      ENDOGENOUS NITRIC-OXIDE PROTECTS AGAINST THROMBOEMBOLISM IN VENULES BUT NOT IN ARTERIOLES

      Arteriosclerosis, thrombosis, and vascular biology
    22. MAKKAR RR; EIGLER NL; KAUL S; FRIMERMAN A; NAKAMURA M; SHAH PK; FORRESTER JS; HERBERT JM; LITVACK F
      EFFECTS OF CLOPIDOGREL, ASPIRIN AND COMBINED THERAPY IN A PORCINE EX-VIVO MODEL OF HIGH-SHEAR INDUCED STENT THROMBOSIS

      European heart journal
    23. LEE JY; LEE MY; CHUNG SM; CHUNG JH
      CHEMICALLY-INDUCED PLATELET LYSIS CAUSES VASOCONSTRICTION BY RELEASE OF SEROTONIN

      Toxicology and applied pharmacology
    24. HATA K; WHITTAKER P; KLONER RA; PRZYKLENK K
      BRIEF ANTECEDENT ISCHEMIA ATTENUATES PLATELET-MEDIATED THROMBOSIS IN DAMAGED AND STENOTIC CANINE CORONARY-ARTERIES - ROLE OF ADENOSINE

      Circulation
    25. Katoh, A; Ikeda, H; Murohara, T; Haramaki, N; Ito, H; Imaizumi, T
      Platelet-derived 12-hydroxyeicosatetraenoic acid plays an important role in mediating canine coronary thrombosis by regulating platelet glycoprotein IIb/IIIa activation

      CIRCULATION
    26. MUSSELMAN DL; EVANS DL; NEMEROFF CB
      THE RELATIONSHIP OF DEPRESSION TO CARDIOVASCULAR-DISEASE - EPIDEMIOLOGY, BIOLOGY, AND TREATMENT

      Archives of general psychiatry
    27. HEIJMEN RH; GRUNDEMAN PF; BORST C
      INTIMA-ADVENTITIA APPOSITION IN END-TO-SIDE ARTERIAL ANASTOMOSIS - ANEXPERIMENTAL-STUDY IN THE PIG

      The Annals of thoracic surgery
    28. DUVAL N; GROSSET A; OCONNOR SE
      COMBINATION OF ASPIRIN AND METOCLOPRAMIDE PRODUCES A SYNERGISTIC ANTITHROMBOTIC EFFECT IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS

      Fundamental and clinical pharmacology
    29. HERMSMEYER K; MIYAGAWA K; KELLEY ST; ROSCH J; HALL AS; AXTHELM MK; GREENBERG B
      REACTIVITY-BASED CORONARY VASOSPASM INDEPENDENT OF ATHEROSCLEROSIS INRHESUS-MONKEYS

      Journal of the American College of Cardiology
    30. GUTH BD; MULLER TH
      DTTX30, A COMBINED THROMBOXANE RECEPTOR ANTAGONIST AND THROMBOXANE SYNTHETASE INHIBITOR, PREVENTS CORONARY-THROMBOSIS IN ANESTHETIZED DOGS

      Basic research in cardiology
    31. OSKARSSON HJ; HOFMEYER TG; OLIVARI MT
      CYCLOSPORINE IMPAIRS THE ABILITY OF HUMAN PLATELETS TO MEDIATE VASODILATION

      Hypertension
    32. VALENTIN JP; VIEU S; BERTOLINO F; FAURE P; JOHN GW
      DIFFERENTIAL INVOLVEMENT OF SEROTONIN 2A C AND THROMBOXANE-A(2)/PROSTANOID RECEPTORS IN HIGH-SHEAR VS LOW-SHEAR RATE ARTERIAL THROMBOSIS INRABBITS/

      The Journal of pharmacology and experimental therapeutics
    33. SILL JC; BERTHA B; BERGER I; UHL C; NUGENT M; FOLTS J
      HUMAN PLATELET CA2+ MOBILIZATION, GLYCOPROTEIN IIB IIIA ACTIVATION, AND EXPERIMENTAL CORONARY-THROMBOSIS IN-VIVO IN DOGS ARE ALL INHIBITED BY THE INOTROPIC AGENT AMRINONE/

      Circulation
    34. LEO R; PRATICO D; IULIANO L; PULCINELLI FM; GHISELLI A; PIGNATELLI P; COLAVITA AR; FITZGERALD GA; VIOLI F
      PLATELET ACTIVATION BY SUPEROXIDE ANION AND HYDROXYL RADICALS INTRINSICALLY GENERATED BY PLATELETS THAT HAD UNDERGONE ANOXIA AND THEN REOXYGENATED

      Circulation
    35. FUJISE K; REVELLE BM; STACY L; MADISON EL; YEH ETH; WILLERSON JT; BECK PJ
      A TISSUE-PLASMINOGEN ACTIVATOR P-SELECTIN FUSION PROTEIN IS AN EFFECTIVE THROMBOLYTIC AGENT/

      Circulation
    36. AMBROSIO G; TRITTO I; GOLINO P
      REACTIVE OXYGEN METABOLITES AND ARTERIAL THROMBOSIS

      Cardiovascular Research
    37. ROBERTS WC
      WILLERSON,JAMES,THORNTON, MD - A CONVERSATION WITH THE EDITOR

      The American journal of cardiology
    38. JEREMY JY; JACKSON CL; BRYAN AJ; ANGELINI GD
      EICOSANOIDS, FATTY-ACIDS AND RESTENOSIS FOLLOWING CORONARY-ARTERY BYPASS GRAFT-SURGERY AND BALLOON ANGIOPLASTY

      Prostaglandins, leukotrienes and essential fatty acids
    39. WILLERSON JT; IGO SR; YAO SK; OBER JC; MACRIS MP; FERGUSON JJ
      LOCALIZED ADMINISTRATION OF SODIUM-NITROPRUSSIDE - ENHANCES ITS PROTECTION AGAINST PLATELET-AGGREGATION IN STENOSED AND INJURED CORONARY-ARTERIES

      Texas Heart Institute journal
    40. SUDO YJ; LUCCHESI BR
      ANTITHROMBOTIC EFFECT OF GYKI-14766 IN A CANINE MODEL OF ARTERIAL ANDVENOUS RETHROMBOSIS - A COMPARISON WITH HEPARIN

      Journal of cardiovascular pharmacology
    41. MENYS VC; SMITH CCT; LEWINS P; FARMER RDT; NOBLE MIM
      PLATELET 5-HYDROXYTRYPTAMINE IS DECREASED IN A PRELIMINARY GROUP OF DEPRESSED-PATIENTS RECEIVING THE 5-HYDROXYTRYPTAMINE REUPTAKE INHIBITING DRUG FLUOXETINE

      Clinical science
    42. ANFOSSI G; TROVATI M
      ROLE OF CATECHOLAMINES IN PLATELET-FUNCTION - PATHOPHYSIOLOGICAL AND CLINICAL-SIGNIFICANCE

      European journal of clinical investigation
    43. WILLERSON JT
      INHIBITORS OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTORS - WILL THEY BEUSEFUL WHEN GIVEN CHRONICALLY/

      Circulation
    44. MAALEJ N; FOLTS JD
      INCREASED SHEAR-STRESS OVERCOMES THE ANTITHROMBOTIC PLATELET INHIBITORY EFFECT OF ASPIRIN IN STENOSED DOG CORONARY-ARTERIES

      Circulation
    45. BIASUCCI LM; LIUZZO G; CALIGIURI G; QUARANTA G; ANDREOTTI F; SPERTI G; VANDEGREEF W; REBUZZI AG; KLUFT C; MASERI A
      TEMPORAL RELATION BETWEEN ISCHEMIC EPISODES AND ACTIVATION OF THE COAGULATION SYSTEM IN UNSTABLE ANGINA

      Circulation
    46. MOLLER P; WALLIN H; KNUDSEN LE
      OXIDATIVE STRESS ASSOCIATED WITH EXERCISE, PSYCHOLOGICAL STRESS AND LIFE-STYLE FACTORS

      Chemico-biological interactions
    47. SHAW LA; COKER SJ
      SUPPRESSION OF REPERFUSION-INDUCED ARRHYTHMIAS WITH COMBINED ADMINISTRATION OF 5-HT2 AND THROMBOXANE A(2) ANTAGONISTS

      British Journal of Pharmacology
    48. SAITTA A; BONAIUTO M; MILETO A; SQUADRITO F; CAMPO GM; ALTAVILLA D; GIORDANO G; SQUADRITO G; TOTARO S; CINQUEGRANI M; SQUADRITO G
      EFFECTS OF GALLOPAMIL ON EPINEPHRINE AND NOREPINEPHRINE PLASMATIC LEVELS AND ON TXB(2) AND BETA-TG RELEASE IN PATIENTS WITH CORONARY-ARTERYDISEASE DURING ADRENERGIC STIMULUS WITH COLD PRESSOR TEST

      Pharmacological research
    49. FOLTS JD
      DRUGS FOR THE PREVENTION OF CORONARY-THROMBOSIS - FROM AN ANIMAL-MODEL TO CLINICAL-TRIALS

      Cardiovascular drugs and therapy
    50. GOLINO P; RAGNI M; CIRILLO P; PASCUCCI I; EZEKOWITZ MD; PAWASHE A; SCOGNAMIGLIO A; PACE L; GUARINO A; CHIARIELLO M
      AURINTRICARBOXYLIC ACID REDUCES PLATELET DEPOSITION IN STENOSED AND ENDOTHELIALLY INJURED RABBIT CAROTID ARTERIES MORE EFFECTIVELY THAN OTHER ANTIPLATELET INTERVENTIONS

      Thrombosis and haemostasis
    51. WILLERSON JT
      PLATELET, ENDOTHELIUM AND SMOOTH-MUSCLE CELL-DERIVED MEDIATORS CONTRIBUTING TO THE DEVELOPMENT OF UNSTABLE ANGINA AND MYOCARDIAL-INFARCTION

      Fibrinolysis
    52. ANDERSON HV; KIRKEEIDE RL; WILLERSON JT; SMALLING RW; SCHROTH G
      CORONARY-ARTERY FLOW MONITORING - THE VALUE OF INTRAVASCULAR DOPPLER FOR DETECTION OF COMPLICATIONS AFTER INTERVENTIONS

      European heart journal
    53. ANDERSON HV; KIRKEEIDE RL; WILLERSON JT; MISHKEL DC; KJELLGREN O; SMALLING RW; SCHROTH G
      CORONARY-ARTERY FLOW MONITORING FOLLOWING CORONARY INTERVENTIONS

      European heart journal
    54. BIRNBAUM Y; SCLAROVSKY S; HASDAI D; BURSTEIN I; KUSNIEC J; STRASBERG B
      ST SEGMENT REELEVATION AFTER ACUTE MYOCARDIAL-INFARCTION - MARKED DIFFERENCES IN THE ELECTROCARDIOGRAPHIC PATTERN BETWEEN EARLY AND LATE EPISODES

      International journal of cardiology
    55. BEAUGHARD M; BRASSET M; JOHN G; MASSINGHAM R
      FAILURE OF CALCIUM-CHANNEL BLOCKADE TO REDUCE PLATELET-MEDIATED CYCLIC FLOW VARIATIONS IN DOGS WITH CORONARY STENOSIS AND ENDOTHELIAL INJURY

      Journal of cardiovascular pharmacology
    56. MUELLER HW; HAUGHT CA; MCNATT JM; CUI KX; GASKELL SJ; JOHNSTON DA; WILLERSON JT
      MEASUREMENT OF PLATELET-ACTIVATING-FACTOR IN A CANINE MODEL OF CORONARY-THROMBOSIS AND IN ENDARTERECTOMY SAMPLES FROM PATIENTS WITH ADVANCED CORONARY-ARTERY DISEASE

      Circulation research
    57. YAO SK; AKHTAR S; SCOTTBURDEN T; OBER JC; GOLINO P; BUJA LM; CASSCELLS W; WILLERSON JT
      ENDOGENOUS AND EXOGENOUS NITRIC-OXIDE PROTECT AGAINST INTRACORONARY THROMBOSIS AND REOCCLUSION AFTER THROMBOLYSIS

      Circulation
    58. NOBLE MIM; DRAKEHOLLAND AJ
      THE ROLE OF SEROTONIN 5HT(2) RECEPTOR ANTAGONISM IN THE CONTROL OF CORONARY-ARTERY DISEASE

      Quarterly Journal of Medicine
    59. ROUX S; CARTEAUX JP; HESS P; FALIVENE L; CLOZEL JP
      EXPERIMENTAL CAROTID THROMBOSIS IN THE GUINEA-PIG

      Thrombosis and haemostasis
    60. COHEN ML; BLOOMQUIST W
      EFFECT OF 5-HT2 RECEPTOR ANTAGONIST ERGOLINES AND THEIR DESISOPROPYL METABOLITES ON RABBIT PLATELET-AGGREGATION IN-VITRO AND EX-VIVO

      Drug development research
    61. TOUSOULIS D; DAVIES G; TENTOLOURIS C; APOSTOLOPOULOS T; KYRIAKIDES M; TOUTOUZAS P
      EFFECTS OF KETANSERIN ON EPICARDIAL CORONARY-ARTERIES AFTER CORONARY ANGIOPLASTY IN PATIENTS WITH STABLE ANGINA

      European heart journal
    62. BELCHER PR; DRAKEHOLLAND AJ; NOBLE MIM
      ANTAGONISM OF THE PLATELET 5HT(2) RECEPTOR IN THE PRESENCE OF THROMBOLYSIS

      International journal of cardiology
    63. GOLINO P; PISCIONE F; BENEDICT CR; ANDERSON HV; CAPPELLIBIGAZZI M; INDOLFI C; CONDORELLI M; CHIARIELLO M; WILLERSON JT
      LOCAL EFFECT OF SEROTONIN RELEASED DURING CORONARY ANGIOPLASTY

      The New England journal of medicine
    64. KAWAI C
      PATHOGENESIS OF ACUTE MYOCARDIAL-INFARCTION - NOVEL REGULATORY SYSTEMS OF BIOACTIVE SUBSTANCES IN THE VESSEL WALL

      Circulation
    65. YAO SK; OBER JC; GARFINKEL LI; HAGAY Y; EZOV N; FERGUSON JJ; ANDERSON HV; PANET A; GORECKI M; BUJA LM; WILLERSON JT
      BLOCKADE OF PLATELET MEMBRANE GLYCOPROTEIN IN RECEPTORS DELAYS INTRACORONARY THROMBOGENESIS, ENHANCES THROMBOLYSIS, AND DELAYS CORONARY-ARTERY REOCCLUSION IN DOGS

      Circulation
    66. BAX WA; RENZENBRINK GJ; VANDERLINDEN EA; ZIJLSTRA FJ; VANHEUVENNOLSEN D; FEKKES D; BOS E; SAXENA PR
      LOW-DOSE ASPIRIN INHIBITS PLATELET-INDUCED CONTRACTION OF THE HUMAN ISOLATED CORONARY-ARTERY - A ROLE FOR ADDITIONAL 5-HYDROXYTRYPTAMINE RECEPTOR ANTAGONISM AGAINST CORONARY VASOSPASM

      Circulation
    67. YAO SK; OBER JC; FERGUSON JJ; MAFFRAND JP; ANDERSON HV; BUJA LM; WILLERSON JT
      CLOPIDOGREL IS MORE EFFECTIVE THAN ASPIRIN AS ADJUVANT TREATMENT TO PREVENT REOCCLUSION AFTER THROMBOLYSIS

      The American journal of physiology
    68. BELCHER PR; DRAKEHOLLAND AJ; HYND JW; NOBLE MIM
      EFFECTS OF TRIMETAZIDINE ON INVIVO CORONARY ARTERIAL PLATELET THROMBOSIS

      Cardiovascular drugs and therapy
    69. KIRCHENGAST M; RUBSAMEN K; LEHMANN HD
      INHIBITION BY THE COMBINED CA2-HT2 RECEPTOR ANTAGONIST NEXOPAMIL (LU-49938) OF INTRACORONARY THROMBUS FORMATION IN A CANINE MODEL OF ARTERIAL-STENOSIS AND INTIMAL DAMAGE( AND 5)

      Journal of cardiovascular pharmacology
    70. GOLINO P; AMBROSIO G; GRESELE P; PASCUCCI I; RAGNI M; RUSSOLILLO E; LEPROUX GB; CHIARIELLO M
      THE IN-VIVO ANTIPLATELET EFFECTS OF THROMBOXANE-A(2) SYNTHASE INHIBITORS ARE POTENTIATED BY SIMULTANEOUS THROMBOXANE A(2) PROSTAGLANDIN-H-2RECEPTOR BLOCKADE/

      The Journal of pharmacology and experimental therapeutics
    71. SERRUYS PW; KLEIN W; TIJSSEN JPG; RUTSCH W; HEYNDRICKX GR; EMANUELSSON H; BALL SG; DECOSTER O; SCHROEDER E; LIBERMAN H; EICHHORN E; WILLERSON JT; ANDERSON HV; KHAJA F; ALEXANDER RW; BAIM D; MELKERT R; VANOENE JC; VANGOOL R
      EVALUATION OF KETANSERIN IN THE PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - A MULTICENTER RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL

      Circulation
    72. GOLINO P; AMBROSIO G; RAGNI M; PASCUCCI I; TRIGGIANI M; ORIENTE A; MCNATT J; BUJA LM; CONDORELLI M; CHIARIELLO M; WILLERSON JT
      SHORT-TERM AND LONG-TERM ROLE OF PLATELET-ACTIVATING-FACTOR AS A MEDIATOR OF IN-VIVO PLATELET-AGGREGATION

      Circulation
    73. MCAULIFFE SJG; SNOW HM; COX B; SMITH CCT; NOBLE MIM
      INTERACTION BETWEEN THE EFFECTS OF 5-HYDROXYTRYPTAMINE AND ADRENALINEON THE GROWTH OF PLATELET THROMBI IN THE CORONARY-ARTERY OF THE ANESTHETIZED DOG

      British Journal of Pharmacology
    74. STRONY J; BEAUDOIN A; BRANDS D; ADELMAN B
      ANALYSIS OF SHEAR-STRESS AND HEMODYNAMIC FACTORS IN A MODEL OF CORONARY-ARTERY STENOSIS AND THROMBOSIS

      The American journal of physiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 23:33:47